ARS Pharmaceuticals, Inc. (SPRY)
Nasdaq: SPRY · Pharmaceutical Preparations · San Diego, CA · filing with the SEC since 2016
Who owns ARS Pharmaceuticals, Inc.
As filed with the SECHolders of 5% or more
4
RA Capital Management, L.P. holds 11.1% of Common Stock, par value $0.0001 per share, as its SCHEDULE 13D/A filed Oct 1, 2025 says.
Directors and officers
23
report now, of 44 people on the record since 2020. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 4 named at left.
Holders of 5% or moreshare of the class, as filed
RA Capital Management, L.P.
SCHEDULE 13D/A · filed Oct 1, 2025 · Common Stock, par value $0.0001 per share
Rubric Capital Management LP
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock, par value $0.0001 per share · 6.27% in Feb 13, 2026
Deerfield Management Company, L.P.
SCHEDULE 13D/A · filed Aug 1, 2025 · Common Stock, par value $0.0001 per share · 8.79% in Jul 22, 2025
Blackrock, Inc.
SCHEDULE 13G · filed Jul 27, 2026 · Common Stock · 4.98% in Apr 27, 2026
Millennium Management LLC
SCHEDULE 13G/A · filed Jul 14, 2026 · Common Stock, par value $0.0001 per share · reported falling below 5%, from 6% in Mar 31, 2026
What SPRY reports owning in othersstakes of 5% or more, and other ties
2 subsidiaries in 2 countries, from the list filed with the 10-K filed Mar 21, 2024.
Insider tradesForm 4
5sales
0purchases
2sales on a scheduled plan
4people selling
$1.9Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Nov 4, 2025 to Nov 4, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 4, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window4 of 50 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Chakma Justin | Chief Business Officer | 2 | $1.5M | 0 | 0 | $0 |
| Karas Eric | Chief Commercial Officer | 1 | $300,000 | 1 | 0 | $0 |
| Dorsey Brian | Chief Operating Officer | 1 | $200,000 | 0 | 0 | $0 |
| Fitzpatrick Alexander A | Chief Legal Officer | 1 | $0 | 1 | 0 | $0 |